Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasulin in Type 1 Diabetes
NCT00850161Phase 2Withdrawn
- Sponsor
- CPEX Pharmaceuticals, Inc.
- Start
- Jul 2009
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of insulin icodec in type 1 diabetes mellitus (T1D), sponsored by CPEX Pharmaceuticals, Inc.. Planned start Jul 2009; status: withdrawn.
02
Drugs
insulin icodec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00850161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00850161.